Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

Go back to Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

Organogenesis Holding (ORGO) Reports Q4 EPS of $0.15

March 16, 2021 4:15 PM EDT

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.15, versus ($0.04) reported last year. Revenue for the quarter came in at $106.8 million, versus $74.65 million reported last year.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

... More